{'Year': '2023', 'Month': 'Jan'}
Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a <i>DPYD</i> variant and decreased dihydropyrimidine dehydrogenase enzyme activity.
To investigate if dihydropyrimidine dehydrogenase phenotyping has added value when combined with <i>DPYD</i> genotyping in predicting fluoropyrimidine-related toxicity.